XORTX Therapeutics Cash Flow Statement (2020-2026) | XRTX

Cash Flow Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-0.18M-6.64M9.84M-2.70M-1.24M-1.20M-2.15M-1.83M-1.26M-3.02M0.17M-0.59M6.75M-0.70M-0.72M-0.65M-0.59M-0.81M
Share-based Compensation (Quarter)
0.07M0.05M0.11M0.07M0.33M0.02M0.07M0.04M0.03M0.02M0.03M0.05M0.04M0.02M0.01M0.01M0.01M0.01M0.00M0.01M
Gains from Equity Investments (Quarter)
-0.53M6.30M-4.20M-0.33M-1.13M-0.36M-1.58M1.72M-1.65M-0.24M1.20M-0.25M-0.15M-0.08M-0.09M-0.01M
Gains from Investment Securities (Quarter)
0.13M0.03M
Non-cash Items (Quarter)
-0.02M-0.05M13.88M-2.50M-1.88M-0.95M-3.80M-2.49M-1.73M-1.07M11.87M1.70M-3.74M-0.75M6.47M-0.64M-0.79M-0.63M-0.70M-0.50M
Cash from Operations (Quarter)
0.95M-13.84M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.00M0.00M0.00M0.00M0.00M0.03M0.02M0.05M0.01M-0.00M0.08M0.01M0.01M0.01M0.09M0.01M0.01M0.01M0.09M0.00M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.01M0.01M-0.03M0.02M0.02M0.02M0.02M0.02M
Change in Working Capital
Change in Receivables (Quarter)
-0.08M-0.07M0.12M-0.02M0.05M0.01M-0.04M0.01M0.03M0.01M0.01M-0.00M385.000.01M-0.01M-0.06M0.02M
Change in Accured Expenses (Quarter)
0.36M-0.02M-0.73M0.28M0.44M0.20M-0.31M0.12M0.08M0.09M-0.15M-0.40M0.43M0.11M0.07M-0.00M0.09M0.07M0.01M-0.03M
Investing Activities
Capital Expenditures (Quarter)
-444.710.03M-0.00M-0.00M0.01M
Change in Intangibles (Quarter)
-0.01M-0.01M0.05M-0.00M-0.01M-0.01M-0.01M-0.02M-0.01M-0.01M0.07M-0.00M-0.01M-0.02M0.07M-0.00M-0.02M-0.01M-0.02M-0.00M
Cash from Investing Activities (Quarter)
0.01M-0.07M
Financing Activities
Other financing activities (Quarter)
0.38M-1.12M-0.01M-0.30M-0.02M0.00M-0.27M-0.08M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
-0.02M0.49M1.17M0.47M0.18M0.01M0.32M0.16M0.05M0.05M0.51M0.09M0.11M0.02M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
13.23M2.00M1.50M0.11M1.04M1.10M
Dividend Payments
Dividends Paid - Common (Quarter)
-0.73M-0.12M12.24M-1.64M7.91M-1.74M-1.09M3.84M-0.76M-0.78M1.90M-0.83M0.13M0.25M
Misc.
Cash from Financing Activities (Quarter)
0.49M4.27M
Exchange Rate Effect (Quarter)
0.00M0.26M-0.13M0.27M0.48M0.05M0.00M0.00M-246.00-0.00M-0.01M-0.00M0.02M-0.04M0.00M0.03M-0.01M0.00M-763.00
Change in Cash (Quarter)
-0.73M-0.12M10.99M-2.64M7.02M0.83M-8.41M-2.53M-1.74M-1.09M-1.62M0.39M-0.76M-0.78M0.17M-0.58M-0.83M0.13M-0.33M-0.61M
Beginning Cash Balance (Quarter)
14.88M10.43M3.45M2.47M0.86M
Free Cash Flow (Quarter)
0.95M-13.87M0.00M0.00M
Net Cash Flow (Quarter)
1.44M-9.64M